Processa Pharmaceuticals, Inc. (PCSA)
NASDAQ: PCSA · Real-Time Price · USD
0.860
-0.020 (-2.26%)
At close: Nov 22, 2024, 4:00 PM
0.870
+0.010 (1.16%)
After-hours: Nov 22, 2024, 7:57 PM EST

Processa Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2015
Period Ending
Nov '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2015
Market Capitalization
3818777099
Upgrade
Market Cap Growth
-27.52%-53.15%-77.16%10.52%-29.44%-29.07%
Upgrade
Enterprise Value
029587198
Upgrade
Last Close Price
0.866.6922.0098.00131.90360.00
Upgrade
PB Ratio
0.761.652.353.023.0412.32
Upgrade
P/TBV Ratio
1.201.652.354.424.94-
Upgrade
Debt / Equity Ratio
0.030.030.030.000.010.13
Upgrade
Quick Ratio
2.376.446.5117.0612.820.58
Upgrade
Current Ratio
3.977.718.4018.8713.270.85
Upgrade
Return on Equity (ROE)
-211.71%-178.52%-166.43%-47.20%-93.14%-37.91%
Upgrade
Return on Assets (ROA)
-113.11%-99.41%-72.18%-27.98%-22.29%-21.05%
Upgrade
Return on Capital (ROIC)
-132.05%-111.54%-76.12%-29.61%-24.90%-25.93%
Upgrade
Earnings Yield
-410.20%-134.94%-155.91%-14.84%-20.69%-3.40%
Upgrade
FCF Yield
-395.90%-97.87%-54.61%-11.32%-4.51%-2.78%
Upgrade
Buyback Yield / Dilution
-117.51%-62.83%-5.16%-104.27%-35.72%-3.63%
Upgrade
Total Shareholder Return
-117.51%-62.83%-5.16%-104.27%-35.72%-3.63%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.